Pershing Edward
- SEC CIK
- 0001689739
No open-market purchases or sales filed in the past year.
Current role at each company
- PVCT Provectus Biopharmaceuticals, Inc.CEOas of Sep 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pershing Edward as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Pershing EdwardCEO | PPurchase | +349.4K | $0.286 | +$99.9K | –2.61M after | Derivative |
| Nov 25, 2024 (view filing) | Nov 22 | 3 days | Pershing EdwardCEO | PPurchase | +803.6K | $0.286 | +$229.8K | –1.69M after | Derivative |
| Oct 19, 2023 (view filing)5:16 PM ET | Oct 3 | 16 daysLate | Pershing EdwardDirector | PPurchase | +193.1K | $0.2862 | +$55.3K | –690.8K after | Derivative |